The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction

2018 ◽  
Vol 92 (6) ◽  
pp. 1209-1214 ◽  
Author(s):  
Jian Ye ◽  
Arthur J. Lee ◽  
Philipp Blanke ◽  
John Webb
2016 ◽  
Vol 203 ◽  
pp. 672-674 ◽  
Author(s):  
Enrico Fabris ◽  
Andrea Perkan ◽  
Elisabetta Rauber ◽  
Giancarlo Vitrella ◽  
Roberto Sallusti ◽  
...  

2020 ◽  
Vol 7 (12) ◽  
pp. 201838
Author(s):  
Romina Plitman Mayo ◽  
Halit Yaakobovich ◽  
Ariel Finkelstein ◽  
Shawn C. Shadden ◽  
Gil Marom

Leaflet thrombosis has been suggested as the reason for the reduced leaflet motion in cases of hypoattenuated leaflet thickening of bioprosthetic aortic valves. This work aimed to estimate the risk of leaflet thrombosis in two post-valve-in-valve (ViV) configurations, using five different numerical approaches. Realistic ViV configurations were calculated by modelling the deployments of the latest version of transcatheter aortic valve devices (Medtronic Evolut PRO, Edwards SAPIEN 3) in the surgical Sorin Mitroflow. Computational fluid dynamics simulations of blood flow followed the dry models. Lagrangian and Eulerian measures of near-wall stagnation were implemented by particle and concentration tracking, respectively, to estimate the thrombogenicity and to predict the risk locations. Most of the numerical approaches indicate a higher leaflet thrombosis risk in the Edwards SAPIEN 3 device because of its intra-annular implantation. The Eulerian approaches estimated high-risk locations in agreement with the wall sheer stress (WSS) separation points. On the other hand, the Lagrangian approaches predicted high-risk locations at the proximal regions of the leaflets matching the low WSS magnitude regions of both transcatheter aortic valve implantation models and reported clinical and experimental data. The proposed methods can help optimizing future designs of transcatheter aortic valves with minimal thrombotic risks.


Author(s):  
J. James Edelman ◽  
Jaffar M. Khan ◽  
Toby Rogers ◽  
Christian Shults ◽  
Lowell F. Satler ◽  
...  

An increasing number of surgically implanted bioprostheses will require re-intervention for structural valve deterioration. Valve-in-valve transcatheter aortic valve replacement (ViV TAVR) has become an alternative to reoperative surgery, currently approved for high-risk and inoperable patients. Challenges to the technique include higher rates of prosthesis–patient mismatch and coronary obstruction, compared to native valve TAVR. Herein, we review results of ViV TAVR and novel techniques to overcome the aforementioned challenges.


2016 ◽  
Vol 12 (9) ◽  
pp. 1195-1195 ◽  
Author(s):  
Fabien Praz ◽  
Aris Moschovitis ◽  
Stefan Stortecky ◽  
Thomas Pilgrim ◽  
Balthasar Eberle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document